The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from ...